2nd Quarter - Report
LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA
Firm
Client
Income
$51,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 23 America Invents Act; HR 1249 America Invents Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President for Legislative Affairs |
Health Issues HCR
implementation of Patient Protection and Affordable Care Act; Generic Drug User Fees (no bill yet); drug shortage (no bill yet).
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President for Legislative Affairs ( |
Medicare/Medicaid MMM
S. 1356 Affordable Medicines Utilization Act of 2011; Medicaid drug rebates in context of debt limit legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President for Legislative Affairs |
Labor Issues/Antitrust/Workplace LBR
S. 27 Preserve Access to Affordable Generics Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President for Legislative Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.